BioHouston RSS Feed

2013 ABFO National Conference on 28-May-13 8:30 AM

Tue, 28 May 2013 13:30:00 GMT

2013 ABFO National Conference
Start Date: 28-May-13 8:30 AM
End Time: 31-May-13 5:30 PM
Location: Hilton San Diego Bayfront, San Diego, CA 92101
Event Details:

Register Now! www.abfointernational.org/conference

Our early bird discount ends next Tuesday, April 30th

Now is the time to register for the 2013 ABFO National Conference in beautiful San Diego, California! The premier conference for senior bioscience financial officers will be held from May 28 through May 31, 2013 at the Hilton San Diego Bayfront. You don’t want to miss this amazing conference! Our agenda is 2 ½ days full of keynote speakers, breakout sessions, and fun events as well as plenty of time to network with your peers in life sciences.

Today's featured keynote speaker is Karin Eastham. Karin’s presentation is entitled “An Insider’s Guide: What Directors Expect from the CFO Today”. Karin has over 30 years of financial and operations management and she currently serves as a director for four public biotechnology companies; Illumina, Inc., Geron Corporation, Trius Therapeutics, Inc. and MorphoSys AG.

Karin will discuss how the CFO needs to master the technical skills of the job, but also be an exceptional leader and implement processes that allow to the Board to fulfill its obligations to the company. She’ll provide participants with tools for effective Board preparation and helpful tips on how to engage the Board. Karin will also discuss tips for effective leadership based on lessons learned in the CFO’s chair, the boardroom as well as the kitchen. Karin will have copies of her book, Cook the Part, available after her presentation and would be glad to sign copies.

Choose from our breakout session topics of: Avoiding IPO Pitfalls, Current D&O Landscape and Say on Pay, Effective Management of Clinical Trials and CROs, Lean In Biosciences, Accounting & SEC Update, Treasury-Navigating Change, M&A Considerations and The Role of Orphan Drugs in Biotech/Pharma Today.

And of course, our keynote speakers:

Michael Abrashoff, Former Navy Commander and Author
Joe Quinlan, Managing Director & Chief Market Strategist, U.S. Trust, Bank of America, Private Wealth Management
Daniel Bradbury, Former CEO, Amylin Pharmaceuticals, Inc.
Mark Foletta, Former CFO, Amylin Pharmaceuticals, Inc.
Karin Eastham, Board Member – MorphoSys AG, Trius Therapeutics, Illumina, Crosswalk Press LLC, Geron
Larry Smith, FASB Member
Dr. Stanley Rockson, Chief of Consultative Cardiology at Stanford University School of Medicine

This conference is also a great way for you to obtain up to 18 CE credits while networking with your peers across bioscience.

Remember that this conference isn’t just about work – we have some great nightly activities planned! We will attend a Padres game on Wednesday night in the historic Petco Park Western Metals building, and we have a fantastic Mystery Event planned for Thursday night (it’s like nothing we’ve ever done before!). The entire agenda is available HERE.

The cost for this great conference is only $1,200. Register now as the price will increase to $1,300 after April 30, 2013! Registration is easy at www.abfointernational.org/conference.

Hilton San Diego Bayfront

1 Park Boulevard

San Diego, CA 92101

BioHouston Breakfast Forum on 13-Jun-13 7:30 AM

Thu, 13 Jun 2013 12:30:00 GMT

BioHouston Breakfast Forum
Start Date: 13-Jun-13 7:30 AM
End Time: 13-Jun-13 9:00 PM
Location: BRC first floor exhibit space, Houston, Texas 77030
Speaker: Gregg Sando

Event Details:

**PLEASE NOTE: For this Breakfast Forum, we are requiring payment prior to the event in order to ensure an accurate headcount for ordering food. The "Pay at Event" option will not be available when pre-registering online.

BioHouston will still welcome walk-ups for this event. However, all walk-up pricing will be set at the $40.00 rate regardless of current membership status. We appreciate your patience and understanding.

**NO refunds will be given after June 6, 2013.

BRC first floor exhibit space

6500 Main Street

Houston, Texas 77030

Advances in Tissue Engineering 2013 on 14-Aug-13 8:30 AM

Wed, 14 Aug 2013 13:30:00 GMT

Advances in Tissue Engineering 2013
Start Date: 14-Aug-13 8:30 AM
End Time: 17-Aug-13 5:30 PM
Location: Rice University's BioScience Research Collaborative (BRC), Houston, TX 77030
Event Details:

Advances in Tissue Engineering 2013
21st Annual Short Course
August 14 through 17, 2013
Rice University, Houston, Texas

Focusing on advances in the science and technology of tissue engineering

and featuring leading scientists from Rice University, the Texas Medical Center, industry, and other institutions.
The course will survey the latest knowledge and technologies in the world of patient-specific therapeutics -

from transplantation of cells and tissues to artificial organs.

Course Features

Program & Speakers

CONTACT AND INFORMATION

EXPLORING HOUSTON

Rice University's BioScience Research Collaborative (BRC)

6500 Main Street

Houston, TX 77030

MDMA 6th Annual Medical Technology Executive Forum on 19-Sep-13 8:00 AM

Thu, 19 Sep 2013 13:00:00 GMT

MDMA 6th Annual Medical Technology Executive Forum
Start Date: 19-Sep-13 8:00 AM
End Time: 19-Sep-13 5:00 PM
Location: Crowne Plaza Cabana, Palo Alto, CA 94306
Event Details:

MDMA's 6th Annual Medical Technology Executive Forum is a unique one-of-a-kind event for CEO's and Senior Executives to meet and discuss the critical issues that affect our industry and the daily challenges faced by medtech companies.

Registration Available Soon!

Agenda

Thursday, September 19, 2013

8:00am - 8:50am

Registration and Continental Breakfast

8;50am - 9:00am

Welcoming Remarks

9:00am - 9:30am

The Value of Medical Technology

9:30am - 10:15am

Raising Capital in a Difficult Environment

10:15am - 10:30am

Networking Break

10:30am - 11:00am

FDA Update: Effort to Improve the Premarket and PostMarket Programs

11:00am - 11:45am

FDA Update: An Industry Perspective

11:45am - 12:05pm

Washington Update: What Lies Ahead for the 2013 Congress

12:05pm - 1:00pm

Networking Lunch

1:00pm - 1:45pm

Understanding the Payor Perspective: What Data is Needed in the Current Environment

1:45pm - 2:30pm

Launching Overseas: The Keys to Successfully Launching Your Product OUS

2:30pm - 2:45pm

Networking Break

2:45pm - 3:30pm

Latest Trends in Compliance and Best Practices

3:30pm - 4:15pm

Building Your Business: Key Issues to Help You Efficiently Grow and Survive

MDMA Member $395

Supporting Organization $495

Non Member $595

CLICK HERE FOR MORE INFORMATION

Crowne Plaza Cabana

4290 El Camino Real

Palo Alto, CA 94306

2013 Texas Life Science CEO Summit on 23-Oct-13 5:30 PM

Wed, 23 Oct 2013 22:30:00 GMT

2013 Texas Life Science CEO Summit
Start Date: 23-Oct-13 5:30 PM
End Time: 25-Oct-13 1:00 PM
Location: Hyatt Regency Lost Pines Resort an Spa, Lost Pines, Texas 78612

Hyatt Regency Lost Pines Resort an Spa

575 Hyatt Lost Pines Road

Lost Pines, Texas 78612

Annual Luncheon Celebrating Women in Science on 30-Oct-13 11:30 AM

Wed, 30 Oct 2013 16:30:00 GMT

Annual Luncheon Celebrating Women in Science
Start Date: 30-Oct-13 11:30 AM
End Time: 30-Oct-13 1:00 PM
Location: River Oaks Country Club, Houston, Texas 77019

River Oaks Country Club

1600 River Oaks Blvd

Houston, Texas 77019

Individual Sponsor on 11-Sep-48 11:30 AM

Fri, 11 Sep 2048 16:30:00 GMT

Individual Sponsor
Start Date: 11-Sep-48 11:30 AM
End Time: 11-Sep-48 1:30 PM
Location: Crystal Ballroom at the Rice Hotel, Houston, TX 77002
Event Details:

2008 Annual Luncheon

Bringing Research to Life

Dr. Elsa Murano

Texas A&M University

September 11, 2008

11:30 AM - 1:30 PM

The Crystal Ballroom at The Rice

909 Texas Ave.

Houston, TX 77002

The upcoming BioHouston annual luncheon, Bringing Research to Life, will feature the new Texas A&M President, Dr. Elsa Murano, as our speaker. Research, particularly in the rapidly expanding life sciences, is the cornerstone in Texas A&M’s quest to become a top-10 public institution by 2020. The impact of this aggressive initiative by the Aggies is far-reaching, as well as critical in expanding the intellectual capital of the state.

Dr. Murano began her professorial career in 1990 as an Assistant Professor in the Department of Microbiology, Immunology and Preventative Medicine at Iowa State, the position she held prior to joining the Texas A&M faculty. She received a bachelor's degree in biological sciences from Florida International University, and earned both a master's degree in anaerobic microbiology and a doctorate in food science and technology from Virginia Tech. Dr. Murano is the first woman and first Hispanic-American to lead the oldest public institution of higher learning in Texas—now one of the largest teaching and research universities in the nation.

Proceeds from the luncheon will benefit BioHouston’s initiatives to build the region’s biotech industry, creating medical breakthroughs that will transform health care, improve lives, and create economic growth.

For questions regarding sponsorship or event information, contact Keisha Curtis at 713-979-9212 or keisha.curtis@biohouston.org

Crystal Ballroom at the Rice Hotel

909 Texas Ave.

Houston, TX US 77002

BioHouston Newsletter 5-Jul-11

Lacey Webster - noemail@biohouston.org — Tue, 05 Jul 2011 21:39:18 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Calendar Events
Releases
Job Listings

Calendar Events for 5-Jul-11 to 1-Oct-11

Summer 2011 Course for Professionals
Speaker's Name:
Day: Monday 8-Aug-11 9:00 AM to Friday 12-Aug-11 5:00 PM
Location:
Summary: A one week bioprocessing training course to familiarize individuals with the process behind biomanufactured goods and therapeutics. Trainees will receive hands on time with a biofermentor to grow a geneti...
Add to Calendar
Posted by: Lacey Webster

Rice University Short Course: Advances In Tissue Engineering
Speaker's Name:
Day: Wednesday 10-Aug-11 8:00 AM to Saturday 13-Aug-11 5:30 PM
Location: Rice University Houston, TX
Summary: COURSE FEATURES The latest on patient-specific therapeutics featuring speakers from academia, medical research, and industry....
Add to Calendar
Posted by: Lacey Webster

BioPharm America 2011: 4th Annual International Partnering Conference
Speaker's Name:
Day: Wednesday 7-Sep-11 8:30 AM to Friday 9-Sep-11 5:30 PM
Location: Westin Boston Waterfront Hotel 425 Summer Street Boston, MA 02210
Summary: BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped...
Mapquest | Add to Calendar
Posted by: Lacey Webster

Annual Luncheon Celebrating Women in Science
Speaker's Name:
Day: Tuesday 20-Sep-11 11:30 AM to 1:00 PM
Location: Rice Hotel, downtown Houston
Summary: By celebrating the achievements of women leaders in science, BioHouston's goal is to inspire others to pursue research and applications that will spur economic growth and prosperity for our region and our state as a whole. ...
Add to Calendar
Posted by: Lacey Webster

Releases for 5-Jun-11 to 5-Jul-11

Baylor College of Medicine and Texas Children's Hospital Neuroscientist Dr. Huda Zoghbi Awarded Gruber Neuroscience Prize

Author:

Release Date: Wednesday 15-Jun-11 8:00 AM

Receives $500,000 Gruber Neuroscience Prize for pioneering work in revealing the genetic and molecular underpinnings of neurological... [More Info]
Posted by: Lacey Webster

Mystic Pharmaceuticals Receives U.S. Patent for Novel Packaging Technology for Drugs and Biologics

Author:

Release Date: Monday 13-Jun-11 11:00 AM

AUSTIN, TX - June 13, 2011 (Business Wire) -- Mystic Pharmaceuticals, Inc. announces today that it has been granted U.S. Patent... [More Info]
Posted by: Lacey Webster

June 9, 2011 - Enabling microRNA Discoveries - 250th peer-reviewed publication made possible by µParaflo® custom microarray technology

Author:

Release Date: Thursday 9-Jun-11 12:00 PM

Houston, TX - LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery... [More Info]
Posted by: Lacey Webster

Study Validates Clinical Accuracy of 50% Dose Reduction for Positron Emission Mammography

Author:

Release Date: Tuesday 7-Jun-11 4:00 PM

PR Newswire SAN ANTONIO, June 7, 2011 SAN ANTONIO, June 7, 2011 /PRNewswire/ -- Presented today at the Society of... [More Info]
Posted by: Lacey Webster

Apollo Endosurgery Taps Michael Doty for CFO

Author:

Release Date: Tuesday 7-Jun-11 8:00 AM

AUSTIN, Texas, June 7, 2011 /PRNewswire/ -- Apollo Endosurgery, Inc., a leading company in the emerging field of flexible surgery,... [More Info]
Posted by: Lacey Webster

Azaya Therapeutics Presents Phase I Data at ASCO and Completes Offering

Author: Lacey Webster

Release Date: Monday 6-Jun-11 11:00 AM

Phase I study conducted at two premier cancer research facilities in Texas $3.5 million convertible debt offering... [More Info]
Posted by: Lacey Webster

Jobs for 5-Jun-11 to 5-Jul-11

Sr. Technology Licensing Associate

Company: The University of Texas Health Science Center at Houston

Date Activated: Tuesday 21-Jun-11 0:00 AM

The University of Texas Health Science Center at Houston (UTHealth) has an immediate opening for the position of Senior Technology... [More Info]
Posted by: Christine Flynn

Director of Quality and Regulatory

Company: Apollo Endosurgery

Date Activated: Thursday 16-Jun-11 12:46 PM

POSITON SUMMARY Reporting directly into the CEO, the Director of Quality and Regulatory will oversee and manage Apollo... [More Info]
Posted by: Lacey Webster

Stay up to date with our RSS feeds.

5-Jul-11 4:39 PM

Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney

Wed, 14 Oct 2009 19:00:00 GMT

Investing in biotech can be scary. Only one out of 10 new drug candidates ever makes it through the gauntlet of clinical trials to become an FDA approved product, and it usually takes hundreds of millions of dollars and a decade or more of research to separate the winners from the losers. Investors usually can’t bother asking serious questions about profit-and-loss statements, or price-to-earnings ratios, until a company is 15 years old or more. And the hype—from gene therapy, to stem cells, to you fill in the blank—can be quite distracting.

So Christopher Henney, 68, who has seen it all in a 30-year career in biotech as co-founder of Immunex, Icos, and Dendreon, knew he had his work cut out yesterday. He was trying to convince a crowd of 100 financial pros at the CFA Society meeting in Seattle that biotech, the classic boom-or-bust industry, is really a good place to invest.

“I want to de-mythologize the scariness,” Henney said at the outset.

Henney started off his talk by reminding the audience how he and Steve Gillis, a pair of immunologists at the Fred Hutchinson Cancer Research Center, went on to start Seattle-based Immunex, one of the members of what he called “the class of 1983.” These were the second-generation companies, following industry pioneer Genentech, that all went public back in a great wave of enthusiasm for biotechnology. The class included Amgen, Biogen, Cetus, Chiron, Genzyme, and Immunex. Seven of the 10 to 12 biotech companies (Henney didn’t name the losers) that went public in that early wave went on to create market valuations that exceeded $1 billion, Henney said.

But even during that great wave of optimism about the power of new genetic engineering technologies for creating new drugs, there were prominent skeptics. Henney told the story of how he and Gillis had a meeting in the early days of Immunex with “one of the doyennes” of the Seattle investment community, whom he didn’t name. Henney and Gillis told their story with great enthusiasm, and got a rude awakening.

“At the end, I remember him saying, ‘I don’t think it’s a scam, but I won’t introduce you to anybody, either,’” Henney recalled.

Both of them were academic scientists who “had a fair amount of hubris about our self-worth. To be told that what we’re doing was a scam, it wasn’t something I wanted to tell my Mom about,” Henney said.

He added, “It was our welcome-to-the-NFL moment.”

Still, the investor taking that position would have been right for the first 15 years or so. It took 17 years from Immunex’s founding before it struck gold with etanercept (Enbrel), a drug for autoimmune diseases that now generates more than $7 billion a year in worldwide sales for Amgen and Wyeth. It took much longer, and hundreds of millions of dollars more than industry pioneers like Henney thought it would, to create blockbuster drugs like that. “If you had thought about that beforehand, nobody would have given us any money at all,” Henney said.

But they got the money, and learned a lot of lessons along the way. In his talk last week, Henney distilled them into six hallmarks of a successful biotech that investors should look for, along with five red flags to watch out for as well (which I’m going to save for another story).

So, here are the six hallmarks to look for in a successful biotech company, according to Henney:

—Solid Patents. All good biotech companies must have terrific science, and they must have patents to protect it, Henney says. In the industry’s early days, there weren’t many patent attorneys that knew what they were doing, but now there are plenty, he says. An investor ought to ask “how does the science stack up” at a company versus its competitors.

—The science should be focused on an important disease, with potential for breakthroughs. Lots of scientists will argue about what’s important and what’s not, but what an investor needs to know is that a biotech company is at the front of the pack. Immunex focused on an important disease, rheumatoid arthritis, and clearly made a breakthough. “You don’t want to be in fourth or fifth place” with a new drug, he says.

—Great management. This is a must in all industries, but it can’t be overstated in biotech. Interestingly, Henney has noticed some unusual character traits about biotech managers that he says shouldn’t scare off investors. “Like you see in software, these are managers who don’t walk into a room and dominate it. They are often fairly nerdy. But we’re talking about people who are smart, efficient managers,” Henney said.

—Access to capital. A company has to be able to prove it can raise money. Again, and again, and again. “Not many biotech companies go out of business because they lack ideas,” Henney said.

—Luck. “You need it. I’m fortunate to say Lady Luck visited me on many occasions,” Henney said. (I’m not sure how investors are supposed to be able to gauge whether a company has luck on its side, though.)

—Flexible attitudes toward human resources. This might sound nutty to straight-laced business school types, but biotech companies need to give breathing room to some brilliant, creative people who aren’t closely directed by management, Henney said. This can work for a small percentage of the top performers, like some of the brightest people at the National Institutes of Health. The most famous case of this in biotech, which Henney didn’t mention, came from Genentech scientist Napoleone Ferrara, who made discoveries in 1989 on his undirected time that gave birth to the breakthrough cancer drug bevacizumab (Avastin).

“You’ve got to let people follow their curiosity,” Henney said. “For some in the business community, that might sound like a sketchy proposition, but you have to.”

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman

14-Oct-09 2:00 PM

MedSource Honored at Houston Fast 100 Event; Ranked No. 11 on List of Fastest Growing Companies

Mon, 21 Sep 2009 20:00:00 GMT

Houston, September 22, 2009 – Houston’s 100 fastest-growing companies and 2009 Power Five were honored at the Houston Fast 100 luncheon presented by the Houston Business Journal and held at the InterContinental Houston Hotel. MedSource, a Contract Research Organization (CRO) specializing in complex clinical trials, was ranked as No. 11 on the Houston Fast 100 list.

Over 700 Houstonians from the business community cheered on the 2009 Fast 100 award recipients at the luncheon on September 11, 2009, where the rankings were first made public. Companies making the list were ranked by percentage of revenue growth over the past two years. MedSource, with a rapid growth rate of more than 213 percent over the past two years, also earned a place on the 2009 Inc. 5000 List.

“We appreciate recognition from the Houston Business Journal and are proud to be a part of Houston’s thriving business community. There is an active biotech community here in Houston, and it is part of our mission to support the goals of that community. MedSource has been able to find traction in this current economy by focusing on quality, service, and integrity. It is what we have built our reputation on and it is how we will continue to do business,” said Eric Lund, president of MedSource.

In addition to the list of Houston’s 100 fastest-growing companies published in the special Houston Fast 100 section of the Houston Business Journal’s September 11, 2009 issue, top executives of some of the honored businesses shared their insights on what to do and what not to do to succeed.

The Houston Fast 100 event was hosted by the Houston Business Journal and presented by Whitney Bank. Co-sponsors of the event were G&A Partners, Pierpont Communications, Reliant Energy, Staples, and Verizon Wireless.

About MedSource

MedSource is a premier Contract Research Organization (CRO) based in Houston, TX dedicated to delivering on-time, reliable clinical trial management services. MedSource has been providing quality results in Phase I-IV studies since 2001 and has extensive experience in complex clinical trials, with a particular expertise on oncology related programs. They have quickly grown into one of the premier CROs in North America and have been recognized as an Inc. 500/5000 company a Houston Fast 100 company. With clinical trial monitors located throughout North America and active vendor relationships globally, MedSource is able to quickly and effectively meet the clinical trial needs of their clients. More information about MedSource can be found at www.medsource.com or by calling (281) 286-2003.

Company contact:

Chris Kohnhorst
(281) 203-7707
ckohnhorst@medsource.com

21-Sep-09 3:00 PM

BioHouston Newsletter 21-May-09

Sara Mathews - noemail@biohouston.org — Thu, 21 May 2009 21:00:00 GMT

<img alt="" src="/attachments/wysiwyg/6638/header.jpg" border="0" height="108" width="795">ntitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

Homeland Security Conference
Day: Wednesday 27-May-09 9:00 AM
Location: InterContinental Hotel, 2222 W. Loop South, Houston, TX 77027
Add to Calendar

CEO Dinner
Day: Thursday 4-Jun-09 5:30 PM
Location: Strip House 1200 McKinney Street Houston, TX 77010
Register Mapquest | Add to Calendar

Breakfast Forum-- Update on State of Texas Bioscience Initiative
Day: Wednesday 10-Jun-09 7:30 AM

Location: M. D. Anderson South Campus Research Building II, 7435 Fannin Street, Houston TX 77054

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Associate Advisory Board
Day: Wednesday 17-Jun-09 11:30 AM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

A Moderated Discussion with Serial Entrepreneur Dale Pfost
Day: Thursday 18-Jun-09 4:00 PM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

BioHouston Annual Luncheon
Day: Friday 11-Sep-09 11:00 AM
Location:
Add to Calendar

The Fall 2009 Engineering Career Fair
Day: Thursday 17-Sep-09 9:00 AM
Location: University of Houston Hilton Hotel 4800 Calhoun Rd Houston, TX 77004
Mapquest | Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 to 13-Nov-09
Location: Houston, TX
Add to Calendar

News

VGXI, Inc. Presents at the ASGT 12th Annual Meeting in San Diego, CA May 27-31

VGXI Inc. Presents Issues Related to High Concentration, Multi-Component Plasmid Products at the American Society of Gene Therapy 12th... [More Info]

FDA clears new KCI abdominal wound-care product

Kinetic Concepts Inc. has received Food and Drug Administration approval on its newest product designed to help patients heal from an... [More Info]

Stericycle to buy MedServe for $185 million

Medical waste handling company MedServe Inc. is being acquired by Stericycle Inc. for $185 million in cash. Houston-based MedServe is... [More Info]

MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial

(Houston, Texas) – May 12, 2009 - MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced... [More Info]

Blausen Introduces New 3D Animations iPhone App

Normal 0 false false false st1\:*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable... [More Info]

Emerging Biotechnology Clusters

Boston, San Francisco, San Diego, and Cambridge are on everyone’s list of the top biotech clusters. Medicon... [More Info]

KCI claims partial victory in patent fight against Smith & Nephew

Kinetic Concepts Inc. (KCI) said Friday that the Patents Court of the High Court of England and Wales has entered a judgment against Smith... [More Info]

Jobs

Human Factors Design Engineer --new

Company: MEI Technologies, Inc.

This position will be within the Anthropometry and Biomechanics Facility (ABF) that is part of the Space Human Factors Laboratory within... [More Info]

Health Outcomes Research Team Leader

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Contract Research Organization seeks an experienced Health Outcomes Research Team Leader... [More Info]

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Stay up to date with our RSS feeds.

21-May-09 4:00 PM

BioHouston Newsletter 1-May-09

Sara Mathews - noemail@biohouston.org — Fri, 01 May 2009 15:41:06 GMT

tled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

Marketing your Medical Device products to the E.U.
Day: Thursday 14-May-09 11:30 AM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

2009 BIO International Conference

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Location: Atlanta, GA
Add to Calendar

Global Intellectual Property Due Diligence--BIO 2009 Session
Sponsor: Baker & McKenzie
Day: Wednesday 20-May-09 10:00 AM
Location: Georgia World Congress Center (Building B)--B313 Atlanta, GA
Add to Calendar

Healthcare Heroes

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

Location: Wortham Center, Houston, TX
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 8:30 AM
Location: Houston, TX
Add to Calendar

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Biomed company shuttering San Antonio operation

British orthopedic device firm Smith & Nephew confirmed Monday that it is closing down its 30-employee facility in San Antonio by the end... [More Info]

Vidacare adds oncology nurse to management

Vidacare Corp. has hired a nationally recognized oncology nursing specialist to join the company’s management. Kim Brodie joined the... [More Info]

Opexa gets $1 million in financing

Opexa Therapeutics Inc. has secured about $1 million through a private offering of secured convertible notes and warrants. The cell... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

1-May-09 10:41 AM

BioHouston Newsletter 1-May-09

Sara Mathews - noemail@biohouston.org — Fri, 01 May 2009 15:28:01 GMT

tled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Biomed company shuttering San Antonio operation

British orthopedic device firm Smith & Nephew confirmed Monday that it is closing down its 30-employee facility in San Antonio by the end... [More Info]

Vidacare adds oncology nurse to management

Vidacare Corp. has hired a nationally recognized oncology nursing specialist to join the company’s management. Kim Brodie joined the... [More Info]

Opexa gets $1 million in financing

Opexa Therapeutics Inc. has secured about $1 million through a private offering of secured convertible notes and warrants. The cell... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

1-May-09 10:28 AM

BioHouston Newsletter 30-Apr-09

Sara Mathews - noemail@biohouston.org — Thu, 30 Apr 2009 18:49:30 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

2009 BIO International Conference

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

Location: Wortham Center, Houston, TX

Add to Calendar

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum

Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 to Friday 13-Nov-09
Location: Houston, TX
Add to Calendar

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

30-Apr-09 1:49 PM

BioHouston Newsletter 16-Apr-09

Tim Graves - noemail@biohouston.org — Thu, 16 Apr 2009 21:34:08 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

ISPE South Central Chapter 10th Annual Educational and Exhibitor Program
Day: Thursday 23-Apr-09 8:30 AM
Location: Crown Plaza 1700 Smith St. Houston, TX 77002
Mapquest | Add to Calendar

2009 BIO International Conference

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

Location: Wortham Center, Houston, TX
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009

Jetro is interested in helping companies set up an office in Japan....and will pay your booth costs.

Sponsor: JETRO-Houston

Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

BioHouston Annual Luncheon--SAVE THE DATE
Day: Friday 11-Sep-09 11:00 AM
Location: Houston, TX
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference--SAVE THE DATE
Day: Wednesday 11-Nov-09 8:30 AM
Location: Houston, TX
Add to Calendar

News

Funding will help Molecular Templates continue developing cancer treatments

Biopharmaceutical company Molecular Templates Inc. has completed a $2.5 million Series A round of financing. Austin-based Molecular... [More Info]

Life Sciences Center attracts Canadian co. Molecular Templates

The Texas Life-Sciences Collaboration Center attracted its first international tenant — a Canadian-based biotech company called Molecular... [More Info]

SeqWright to Invest in LaserGen's Novel Lightning Terminators(TM)

HOUSTON, April 8 /PRNewswire/ -- LaserGen, Inc., a DNA sequencing technology company, announced a definitive agreement in which SeqWright... [More Info]

OncoVista teams up with CTRC to test newest cancer drug

Two San Antonio cancer organizations are working toward the development on a new drug that could be used as a treatment for solid tumors. ... [More Info]

AirStrip software approved for BlackBerry phones

A day after the Food and Drug Administration approved AirStrip Technologies’ obstetrician application on the Apple iPhone, the company... [More Info]

SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems

HOUSTON, April 7 /PRNewswire/ -- SeqWright Inc., an international leader in the field of contract genomic services, announced today its... [More Info]

ULURU Inc. Signs Offer Letter to Acquire York Pharma plc

ADDISON, Texas, April 6 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) today announced that it has signed a non-binding offer... [More Info]

Jobs

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Health Outcomes Research Team Leader

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Clinical Contract Research Organization seeks an experienced Health Outcomes Research... [More Info]

Stay up to date with our RSS feeds.

16-Apr-09 4:34 PM

BioHouston Newsletter 16-Apr-09

Tim Graves - noemail@biohouston.org — Thu, 16 Apr 2009 21:01:39 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, news, jobs and more from our membership.

Events
News
Jobs

Events

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 to Thursday 21-May-09
Location: Atlanta, GA
Add to Calendar

Global Intellectual Property Due Diligence--BIO 2009 Session
Sponsor: Baker & McKenzie
Day: Wednesday 20-May-09 10:00 AM
Location: Georgia World Congress Center (Building B)--B313 Atlanta, GA
Add to Calendar

Houston Business Journal Healthcare Heroes Awards

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM
Location: Wortham Center, Houston, TX
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009

Jetro is interested in helping companies set up an office in Japan...and will pay your booth costs.

Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

BioHouston Annual Luncheon--SAVE THE DATE
Day: Friday 11-Sep-09 11:00 AM
Location: Houston, TX
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference--SAVE THE DATE
Day: Wednesday 11-Nov-09 8:30 AM
Location: Houston, TX
Add to Calendar

News

Funding will help Molecular Templates continue developing cancer treatments

Biopharmaceutical company Molecular Templates Inc. has completed a $2.5 million Series A round of financing. Austin-based Molecular... [More Info]

Life Sciences Center attracts Canadian co. Molecular Templates

The Texas Life-Sciences Collaboration Center attracted its first international tenant — a Canadian-based biotech company called Molecular... [More Info]

SeqWright to Invest in LaserGen's Novel Lightning Terminators(TM)

HOUSTON, April 8 /PRNewswire/ -- LaserGen, Inc., a DNA sequencing technology company, announced a definitive agreement in which SeqWright... [More Info]

OncoVista teams up with CTRC to test newest cancer drug

Two San Antonio cancer organizations are working toward the development on a new drug that could be used as a treatment for solid tumors. ... [More Info]

AirStrip software approved for BlackBerry phones

A day after the Food and Drug Administration approved AirStrip Technologies’ obstetrician application on the Apple iPhone, the company... [More Info]

SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems

HOUSTON, April 7 /PRNewswire/ -- SeqWright Inc., an international leader in the field of contract genomic services, announced today its... [More Info]

ULURU Inc. Signs Offer Letter to Acquire York Pharma plc

ADDISON, Texas, April 6 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) today announced that it has signed a non-binding offer... [More Info]

Jobs

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Health Outcomes Research Team Leader

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Clinical Contract Research Organization seeks an experienced Health Outcomes Research... [More Info]

Stay up to date with our RSS feeds.

16-Apr-09 4:01 PM

BioHouston Newsletter 2-Apr-09: Chili Cook-off tomorrow

Tim Graves - noemail@biohouston.org — Thu, 02 Apr 2009 17:15:56 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, news articles, jobs and more from our membership.

Events
News
Jobs

Events

6th Annual Chili Cook-Off
Register at the Door on Friday -- Yes, that's tomorrow!
Day: Friday 3-Apr-09 12:00 PM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Mapquest | Add to Calendar

Breakfast Forum
David Callender, M.D., President, The University of Texas Medical Branch
Day: Tuesday 14-Apr-09 7:30 AM
Location: M. D. Anderson South Campus Research Building II 7435 Fannin Street Houston, TX 77054
Register Mapquest | Add to Calendar

BioCamp Houston
Day: Saturday 4-Apr-09 9:00 AM
Location: 100 Keck Hall, Rice University Campus 6100 Main St. Houston, TX
Mapquest | Add to Calendar

10th Annual Spring Conference
Day: Thursday 23-Apr-09 8:30 AM
Location: Crown Plaza 1700 Smith St. Houston, TX 77002
Mapquest | Add to Calendar

2009 BIO International Conference
Day: Monday 18-May-09 8:30 AM
Location:
Add to Calendar

Healthcare Heroes Awards
Day: Monday 20-May-09
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

News

San Antonio firm picked to market health care inventory software

Diversified Hospitals & Healthcare Solutions has agreed to serve as a distributor for health care software company VUEMED. Through this... [More Info]

KCI will eliminate 300 positions worldwide

Kinetic Concepts Inc. said Monday that the company is planning on laying off 4 percent of its work force, or 300 employees, worldwide. San... [More Info]

Dallas entrepreneur's latest device interrupts nerve signals to relieve pain

At 29, Will Rosellini has accomplished more than what it takes most people a lifetime to start. The degrees: masters in... [More Info]

Bill Gimson to head Cancer Prevention and Research Institute of Texas

Bill Gimson will lead the new Cancer Prevention and Research Institute of Texas as its executive director. CPRIT is charged with using $3... [More Info]

OncoVista subsidiary awarded U.S. patent for anti-cancer technology

The U.S. Patent and Trademark Office has issued OncoVista Innovative Therapies Inc. and its AdnaGen AG subsidiary a patent for the... [More Info]

Reata Completes Financing and Expands Team to Capture Opportunity Created by Encouraging Clinical Data in Chronic Kidney Disease

Late Stage Clinical Trial Initiated in Patients with Advanced Chronic Kidney Disease IRVING, TX - March 25, 2009 -- Reata Pharmaceuticals,... [More Info]

KV Pharmaceutical layoffs hit The Woodlands

KV Pharmaceutical Co.’s plan to lay off about 1,700 employees has made its way to the Houston area. The St. Louis-based pharmaceutical... [More Info]

VGX working on malaria vaccine for PATH

VGX Pharmaceuticals reached an agreement with the PATH Malaria Vaccine Initiative Monday to design and test DNA vaccine candidates capable... [More Info]

Jobs

Health Outcomes Research Team Leader --new

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Clinical Contract Research Organization seeks an experienced Health Outcomes Research... [More Info]

Stay up to date with our RSS feeds.

2-Apr-09 12:15 PM

Bellicum in Trials with Cancer Vaccine, Cell-Suicide Switches

noemail@biohouston.org — Thu, 16 May 2013 14:00:00 GMT

Less than a decade after being hatched out of a Texas university, Houston-based Bellicum Pharmaceuticals is in the midst of clinical trials on two innovative cancer therapies that, if successful, could result in new ways of attacking and killing off harmful cells. The company uses a platform technology called chemical induction of dimerization, and is in trials on two flagship treatments-a prostate cancer vaccine and a cell-suicide mechanism that can make a currently risky cancer treatment safer to use. In both, immune system cells are implanted with technology that essentially puts an on/off switch inside the cell. A triggering drug, AP1903, flips the switch on, kicking in the desired effect at the right time. AP1903 was created by Massachusetts-based Ariad Pharmaceuticals, which holds an equity stake in the firm and has a licensing deal with Bellicum for the drug. Bellicum has been on a path of growth in recent years. In March 2012, the company announced a$20 million Series B...

PhotoImmune Biotechnology, Inc. has announced the publishing of a third Article on the development of a preventive vaccine for HIV-1.

noemail@biohouston.org — Mon, 13 May 2013 14:00:00 GMT

PhotoImmune Biotechnology, Inc. has announced the publishing of a third Article on the development of a preventive vaccine for HIV-1.

This Article published in the Journal of Virological Methods 189 (2013) 125-128, describes a method for achieving repeatable, complete and irreversible inactivation of HIV-1 viral particles in suspension, using small photo-labeled anti-viral compounds with a high binding specificity for HIV reverse transcriptase(RT).

Dallas Anderson, Pres/CEO stated that PhotoImmune's methodology is currently in 'in vivo' studies at the Department of Virology and Microbiology, Baylor College of Medicine. These in vivo studies are a first step to determine the ability of this inactive, morphologically intact virus to elicit neutralizing antibodies sufficient to provide a basis for HIV immunity.

PhotoImmune Biotechnology, Inc. is a privately held, Delaware 'C' corporation whose patented methodology is applicable to all retro viruses, animal and human.

Contact:

Dallas W Anderson, Pres/CEO

dallaswanderson@gmail.com

Mobile: 713-906-3404

Cell Medica announces treatment of first pediatric patient in early stage clinical trial of Cytovir ADV

noemail@biohouston.org — Wed, 08 May 2013 14:00:00 GMT

Cell Medica today announced the treatment of the first patient in theASPIRE Trial, an early stage Phase I/II clinical study investigating CytovirTM ADV London, UK - 08 May 2013 - Cell Medica today announced the treatment of the first patient in the ASPIRE Trial, an early stage Phase I/II clinical study investigating the safety and efficacy of CytovirTM ADV for the treatment of adenovirus infections in immunosuppressed pediatric patients following bone marrow transplantation. The ASPIRE Trial represents a collaborative R&D project among Cell Medica, UCL Institute of Child Health and the Great Ormond Street Hospital for Children. The project is funded in part by a grant from the Technology Strategy Board, the UK's innovation agency. Cytovir ADV is under development as a new way to treat adenovirus infections in pediatric patients following allogeneic hematopoietic stem cell (bone marrow) transplantation. These patients are profoundly immunosuppressed for a period of three to six...

Capital Royalty Announces $805 Million Fund Closing for Capital Royalty Partners Fund II

noemail@biohouston.org — Thu, 02 May 2013 14:00:00 GMT

Total Investable Capital Expected to Exceed $1 Billion Including Debt Financing HOUSTON, TX May 2, 2013 - Capital Royalty L.P., a pioneer in healthcare investing, today announced the final closing of Capital Royalty Partners II L.P. with $805 million in equity commitments.Capital Royalty Partners II, the Firm's second private equity fund, was oversubscribed and exceeded its initial fund raising target. Total investable capital is expected to exceed $1 billion including debt financing facilities available to the Fund. The Fund's global investor base consists of world-class limited partners, including pension funds, endowments, institutional investors, funds of funds, family offices, and sovereign wealth funds. Capital Royalty Partners II works directly with leading healthcare companies, research institutions, and inventors to offer highly-customized, non-dilutive growth financing solutions to support product commercialization, pipeline development and other...

St. Luke's to Sell to Catholic Health Initiatives

noemail@biohouston.org — Fri, 19 Apr 2013 14:00:00 GMT

EPISCOPAL DIOCESE OF TEXAS APPROVES DEFINITIVE AGREEMENT FOR TRANSFER OF THE ST. LUKE'S EPISCOPAL HEALTH SYSTEM TO CATHOLIC HEALTH INITIATIVES The Episcopal Diocese of Texas approved today a Definitive Agreement for the transfer of St. Luke's Episcopal Health System to Catholic Health Initiatives, a nationally recognized health care system. As part of the transfer of St. Luke's, CHI will contribute more than $1 billion to create a new Episcopal Health Foundation, which will focus on the unmet health needs of the area's underserved population. In addition, CHI has committed an additional $1 billion for future investment in the health system. The Right Reverend C. Andrew Doyle, Bishop of the Episcopal Diocese of Texas, said in announcing the decision, We are humbled to be able to preserve the legacy of St. Luke's, while also expanding the Diocesan commitment to health care. The name of the System will be the St. Luke's Health System. The transaction is expected to be completed...

Oncolix, Inc. Granted U.S. Orphan Drug Status for Treatment of Ovarian Cancer

noemail@biohouston.org — Thu, 18 Apr 2013 14:00:00 GMT

HOUSTON, TX, April 18, 2013 -- Oncolix, Inc. announced today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation to PROLANTA(TM) for the treatment of ovarian cancer. FDA had previously cleared Oncolix's Investigational New Drug Application to commence testing of Prolanta in ovarian cancer patients, and this orphan drug designation provides Oncolix with significant cost and marketing benefits. Prolanta has the potential to be a first-in-class therapy for the treatment of ovarian cancer. Prolanta targets multiple signaling pathways related to both prolactin (~80% of patients) and HER2 (~20% of patients) activity, offering a broad approach to the treatment of ovarian cancer. Prolanta's novel mechanism of action (autophagocytosis or autophagy) may clearly separate this drug from current and other therapies in clinical development. Currently, cytotoxic drugs (chemotherapy) are the only drugs approved for this...

Top 10 U.S. cities for growing businesses

noemail@biohouston.org — Tue, 16 Apr 2013 01:00:00 GMT

LOS ANGELES (MarketWatch) - When a prospective business owner decides where to set up shop, or a promising young graduate considers the best place find a job, they ask themselves the same key question as any savvy investor picking stocks: Where's the most upside? It's also the basic question MarketWatch addresses in new rankings of the 10 cities in 2012 that saw business prosper the most. Using a variety of economic data to evaluate business conditions in the nation's 100 largest metro areas, the survey not only ranks the top and bottom locations, it illuminates the business climate, what powers growth and how well companies are increasing sales, profits and stock prices. The results of Top Cities for Business Growth in 2012 demonstrate that geography has no impact on a region's economic prosperity, and that a healthy business environment can be created just about anywhere - and in relatively short order. It does show that metro areas with strong ties to technology and energy...

Opexa Therapeutics Announces Changes to Senior Management Team

noemail@biohouston.org — Mon, 01 Apr 2013 14:00:00 GMT

THE WOODLANDS, Texas (April 01, 2013) - Opexa Therapeutics, Inc. (NASDAQ: OPXA), a leader in developing a patient specific T-cell immunotherapy for multiple sclerosis (MS) is pleased to announce the strengthening of its management team through the appointment of several key individuals. Karthik Radhakrishnan has been appointed Chief Financial Officer, Kenny Frazier has been appointed Vice President of Clinical Development and Regulatory Affairs and Maryann Murray has been appointed as Clinical Development Manager. Mr. Radhakrishnan joins Opexa as CFO with over 10 years of healthcare capital markets experience and most recently was a Vice President at ING Investment Management in New York. While at ING, he was responsible for healthcare investments in the small & small-mid cap core/growth products that are part of the Fundamental Equity product line. Previously he was the senior analyst at Eagle Asset Management, responsible for large cap growth healthcare. Prior to this, Mr....

Cell Medica announces senior management appointments

noemail@biohouston.org — Thu, 07 Mar 2013 15:00:00 GMT

London/Houston, 7 March 2013 Cell Medica, the cellular therapeutics company bringing to market new personalized cell therapies for the treatment of cancer and infections, today announces key appointments to its senior executive team. The strengthened management team will enable Cell Medica to broaden its product development activities, particularly in the US, and will support further international growth. Dr. Kurt Gunter joins Cell Medica as Chief Medical Officer and will have a senior role in managing the clinical and regulatory aspects of the Company's therapeutic products with a focus on the cancer immunotherapy program. As Chief Financial Officer, Jeff Hammel will be responsible for Cell Medica's global financial and business management systems to drive the continued growth of Cell Medica's commercial operations in both Europe and the US. Ross Durland, PhD, has joined as Senior Vice President...

Professor Mia Markey wins the prestigious Medtronic Prize for Scientific Contributions to Womens Health

noemail@biohouston.org — Mon, 04 Mar 2013 15:00:00 GMT

Dear colleagues, staff members, graduate students and friends of the UT BME Department:

I am delighted to inform you that our colleague Professor Mia Markey of the Biomedical Engineering Department at UT Austin is the 2013 recipient of the prestigious Medtronic Prize for Scientific Contributions to Women’s Health. This award is sponsored by the Society for Women’s Health Research (SWHR) and the Medtronic Foundation who have established an annual prize of $75,000 to recognize a woman scientist or engineer for her contributions to women’s health.

As indicated by SWHR: "The prize encourages women scientists and engineers to work on issues uniquely related to women’s health and rewards women who have devoted a significant part of their careers to this area. The prize honors commitment to the area of sex differences and work to pass this commitment to collaborators and students as both a role model and mentor. The prize is given to an outstanding scientist or engineer in mid-career whose work has led or will lead directly to the improvement of women’s health".

You may find more information about the award and its previous winners in http://www.womenshealthresearch.org/site/PageServer?pagename=rf_researchprize . The previous winners include well known medical scientists from Yale, Johns Hopkins, the University of Pennsylvania, University of North Carolina, Loyola University and Harvard University. Some of these previous recipients have gone on to become HHMI investigators. Mia is the first engineer to receive this award! A formal recognition will be held at a gala event at the SWHR annual meeting at the end of April.

Please congratulate Mia for a great honor!

Mia, we are proud of you and your accomplishments.

Nicholas A. Peppas

Chair, BME Department

Quality Assurance Manager

Mon, 13 May 2013 15:20:34 GMT

Title: Quality Assurance Manager
Description:

Houston, Texas based private company performing adult mesenchymal stem cell services such as banking and expansion for autologous infusion seeks experienced Quality Assurance Manager. Minimum 5 years of experience with Good Manufacturing and/or Good Tissue Practice (GMP/GTP) in pharma or biologics quality required. Extensive quality systems management, controlled document management and SOP writing experience is required. Cell Biology or other biologics GMP/GTP clean room experience preferred. Excellent leadership and communication skills are essential. Salary commensurate with experience. Position immediately available.

Required Experience:
Education Required:
Planned Duration of Employment: Full Time

Contact info:

Lynn Graham (Add to Contacts)

Celltex Therapeutics

2401 FOUNTAIN VIEW DRIVE, UNIT 416

Houston, TX 77057
US

Laboratory Technician

Mon, 13 May 2013 15:20:19 GMT

Title: Laboratory Technician Description: Cell Manufacturing Laboratory Technician: Houston, Texas based private company performing adult mesenchymal stem cell services such as banking and expansion for autologous infusion seeks experienced laboratory technician. Prior experience in cell culturing and cell counting is required. Experience with Good Manufacturing and/or Good Tissue Practices (GMP/GTP) and clean room operations preferred. Salary commensurate with experience. Position immediately available. 0 0 1 70 404 BioHouston 3 1 473 14.0 Normal 0 false false false EN-US JA X-NONE Required...

Quality Control Assistant (US)

Fri, 03 May 2013 21:04:19 GMT

Title: Quality Control Assistant (US) Description: Role 0 0 1 175 998 BioHouston 8 2 1171 14.0 Normal 0 false false false EN-GB JA X-NONE To work under the direction of the Manager QA/QC in a team of driven professionals in a GMP environment on projects related to T cell immunotherapy. The Quality Control Associate works with autologous and allogeneic cell products in accordance to GMP conditions. Together with colleagues in Manufacturing and Quality Assurance the Quality Control Associate will be instrumental in the successful release of patient-specific medicines. In this position individuals...

GMP Manufacturing Technician (US)

Fri, 03 May 2013 21:04:08 GMT

Title: GMP Manufacturing Technician (US) Description: Role 0 0 1 95 543 BioHouston 4 1 637 14.0 Normal 0 false false false EN-GB JA X-NONE To work under the direction of the GMP-Manufacturing Manager, together with driven professionals in a GMP environment on the manufacture of patient specific products for T cell immunotherapy. The GMP-Manufacturing Technician works with autologous and allogeneic cell products in accordance with GMP conditions in a clean-room environment. In this position individuals can make an important contribution to advancing this exciting new area of patient specific...

Research Scientist 3

Fri, 03 May 2013 21:02:28 GMT

Title: Research Scientist 3 Description: Job Purpose Responsible for managing and carrying out clinical research projects. Duties and Responsibilities Responsible for managing projects and supervising associated laboratory activities. Supervise and train laboratory personnel. Adhere to CLIA and GLP SOP's. Adhere to safety protocols. Assure inventory control of reagents, project specimens, and retention. Assure that all laboratory equipment is in good working order and calibrated. Perform quality control on laboratory processes, results, data, and reports. Act as a Project Manager to track the status of projects in the laboratory. Investigate and correct unexpected events. Prepare project work scope and customer proposals. Participate in R&D activities as needed. Working Conditions Job requires some travel and possible long hours and work in the evenings. Physical Requirements Although not physically demanding, reasonably good health...

Post-Doctoral Scientist, Operations

Fri, 03 May 2013 20:56:26 GMT

Title: Post-Doctoral Scientist, Operations Description: Responsible for managing and carrying out research projects in support of the development of methods for clinical operations. Duties and Responsibilities This person will have the responsibility in conducting and managing daily experiments involving rare cell analysis enriched by novel microfluidic device and immunofluorescent analysis using laser scanning cytometry applications. This person will work closely with senior research scientists, engineers, and technical directors to assist with assay development, project design and execution, and generation of reports. Technical applications include basic cellular laboratory techniques with strong emphasis on immunocytochemistry analytical methods. This person will contribute to generation of scientific abstracts, publications and grant applications. He or she will have an opportunity to overlap with research and development laboratory team. The position requires a good team...

Research Assistant

Thu, 18 Apr 2013 16:11:46 GMT

Title: Research Assistant Description: Job Purpose Assist in laboratory activities to support the company's efforts to develop medical devices for cell preparation, characterization, and administration. Duties and Responsibilities Primary job duties and responsibilities include but are not limited to: Performing cell isolations from tissues and maintaining cell cultures Conducting experiments using various cellular, molecular and biochemical methods Analyze data and keep records with proper documentation Share responsibility for laboratory upkeep and cleanliness Provide feedback on product design during development stage Required Experience: Minimum of a B.S. in Biological Sciences or related field and must have relevant work experience This Job Requires the Follow Skills: Ability to multi-task, prioritize project goals, and meet team demands Strong communication and interpersonal skill Position may require handling of hazardous chemicals...

Cell Therapy Technologist

Mon, 15 Apr 2013 16:40:16 GMT

Title: Cell Therapy Technologist Description: ABOUT OPEXA Opexa Therapeutics, Inc. is a biotechnology company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases. Multiple Sclerosis (MS) is a chronic T-cell mediated demyelinating disease of the brain and spinal cord. Our leading product, TcelnaTM, is specifically tailored to each patient's unique T-cell immune response profile to myelin. As such, Tcelna is poised to be the first ever patient specific therapy for MS. Opexa is currently conducting a Phase IIb clinical trial of Tcelna in patients with the secondary progressive form of MS. ABOUT THE CELL THERAPY TECHNOLOGIST OPPORTUNITY Each member of the Opexa team is committed to the goal of bringing novel therapies to market. The Cell Therapy Technologist position offers the exciting opportunity to become fully integrated into the extensive manufacturing process of Tcelna. Through the manufacturing process, the...

Biotechnology Commercialization Center (BCC)

Tue, 02 Apr 2013 18:04:22 GMT

BioHouston has partnered with UT Health for the expansion of wet laboratory facilities available to life science companies. The Biotechnology Commercialization Center (BCC), which is located at The University of Texas Health Science Center at Houston (UTHealth), is available for the incubation of startup companies. The mission of the center is to help facilitate the next breakthrough in the diagnosis or treatment of disease by providing office, laboratory and conference space, as well as access to UTHealth equipment and core analytical facilities. BioHouston’s science laboratory equipment has been relocated to the BCC. The BCC’s proximity to other institutions in the Texas Medical Center provides valuable access to information, collaboration and expertise.

For more information, please visit the BCC website at http://www.uth.tmc.edu/otm/startups/BCC.htm or contact Bruce D. Butler, Ph.D., Vice President for Research and Technology at UTHealth (Bruce.D.Butler@uth.tmc.edu or (713) 500-3369) or Christine E. Flynn, Ph.D., Assistant Director for New Venture Development at UTHealth (Christine.Flynn@uth.tmc.edu or (713) 500-3369).

CEO Dinner

Wed, 06 Mar 2013 14:21:28 GMT

The leaders of Houston region's growing biotechnology industry know the challenges of running a life science company. The CEO Dinner is an opportunity for these leaders to get to know and network with each other in a informal setting, away from the workplace and in one of Houston's finer establishments. These meetings feature a guest speaker pertinent to the industry and plenty of opportunity for networking and discussion. Open only to Life Science company CEO's, this exclusive dinner allows these executives the opportunity to frankly discuss their industry.

For more information, please contact Kim Case at 713.979.9102.

Technology Transfer Luncheon

Wed, 06 Mar 2013 14:20:58 GMT

With more than 40 institutions in the Texas Medical Center and the many additional academic, healthcare and research institutions in the region performing more than $1.8 million in research annually, discoveries of exciting new technologies happen all the time.

The technology transfer office at each institution is the first step towards commercialization of these discoveries. To facilitate interaction between these offices and the investors and life science companies in our region, we host these monthly luncheons.

At each luncheon, a topic of discussion is chosen, and each institution will bring one or more technologies from that arena to review with the group. It may just be an early-stage discovery that has exciting potential, or it may be a patented process ready for licensing. Either way, this is a great opportunity to be in on the ground floor as the discoveries of today become the life-saving products of tomorrow.

Past Meeting Topics:

Biomarkers
Anti-infective Therapeutic and Prophylactic Vaccines
Micro-/Nanoarrays and Medical Devices, including Combination Devices
Immunotherapy
Drug Delivery Systems
Diagnostics
Devices

For more information, please contact Kim Case at 713-979-9102.

Michael E. Debakey Life Science Award

Thu, 28 Feb 2013 19:58:54 GMT

The Michael E. DeBakey Memorial Life Science Award is given each year to the undiscovered life science company with the highest potential to commercialize an important product at the annual Texas Life Science Conference. The first DeBakey Award was given to ThromboVision, Inc. in 2006. Dr. DeBakey's rich history in Houston and the Texas Medical Center, along with his pioneering spirit, truly embodied the qualities that we are seeking in future recipients of this award. Some of Dr. DeBakey's most renowned contributions included the concept of the Mobile Army Surgical Hospitals (MASH units), performing the first successful artificial heart transplant, playing an instrumental role in the development of the Ventricular Assist Device (VAD) and being the first to successfully implant the device into a human. Additionally, he served as consultant to almost every U.S. President in this century and received many prestigious awards, including the Presidential Medal of Freedom with...

Board--Executive Committee--Northcut

Mon, 17 Dec 2012 15:53:47 GMT

Jacqueline R. Northcut
President and CEO

BioHouston, Inc.

Jacqueline Northcut joined BioHouston as its President and CEO in December 2002, creating an organization that is the foundation for what BioHouston has become today. Over the last 25 years she has assisted the governor and two mayors of Houston in their efforts to create a sustainable industry in the state. She is also the CEO of Texas BioAlliance, an organization affiliated with BioHouston.

Prior to joining BioHouston, Jacqueline was a partner with Arthur Andersen. For 18 years, she worked with emerging businesses from the initial start up phase through maturity in various industries including biotechnology, venture capital, medical device and several service industries including numerous initial public offerings and rollups. While at Arthur Andersen she led several biotechnology industry initiatives including the national Association for Biotechnology Financial Officers. She has a demonstrated track record of experience and leadership in public and private financings and mergers and acquisitions.

She received her BBS from Harding University in 1984.

Associate Advisory Board

Fri, 14 Sep 2012 19:35:05 GMT

Meg Boulware - Chair Boulware & Valoir Danguole Altman Vapogenix William Altman CorInnova Bill Arend Oracle Meredith Brown AlphaDev Wendy Burke HOAR Construction Hoagy Cannon Vaughn Construction David Carter Capital Royalty Michael Coleman InGeneron John Farrell FKP Architects Bruce Given, MD ICON plc David Hartland Insperity Karen...

Board--Executive Committee--Given

Tue, 07 Feb 2012 15:39:12 GMT

Bruce D. Given, M.D. Chief Operating Officer, Arrowhead Research Corporation Dr. Given currently serves as Chief Operating Officer of Arrowhead Research Corporation. From 2002 to 2007 Dr. Given served as President, Chief Executive Officer and member of the Board of Directors of Encysive Pharmaceuticals. In addition, he has held senior operational roles with Johnson & Johnson as President, International for Ortho Clinical Diagnostics and Group Vice President and Head, Research and Development, Sales and Marketing for Janssen Pharmaceutica(US), as well as various executive and senior management positions at Sandoz Pharma Ltd., Sandoz Research Institute and Schering-Plough Corporation. Before entering the pharmaceutical industry, Dr. Given was on the medical faculty at the University of Chicago. Since February 1, 2010, Dr. Given has served as Chief Executive Officer of Leonardo Biosystems, Inc., a company in which Arrowhead maintains a...

Board: Daniel J. Moore

Fri, 16 Sep 2011 15:07:36 GMT

Daniel J. Moore.
President & Chief Executive Officer
Cyberonics, Inc.

Dan Moore became President and Chief Executive Officer of Cyberonics in May 2007. During the first three years of his tenure, the Company resumed meaningful epilepsy revenue growth and returned to profitability after multiple years of losses. Net sales for fiscal year 2010 were $167.8 million resulting in income from operations of $36.9 million. Under the direction of Mr. Moore and his senior management team, Cyberonics is focused on introducing medical devices and expanding Vagus Nerve Stimulation (VNS) Therapy® franchise for patients suffering from epilepsy.

Cyberonics has approximately 500 employees world-wide, with more than 430 in the U.S. Cyberonics’ stock is traded on the NASDAQ stock exchange under the symbol CYBX.

Mr. Moore joined Cyberonics from Boston Scientific where, since 1989, he held positions in sales, marketing and senior management in the United States and in Europe. In his last position at Boston Scientific, he was President, International Distributor Management. Prior to this, he was President, Inter-Continental, the fourth largest business unit of Boston Scientific with more than 1,000 global employees and revenues exceeding $700 million. Mr. Moore began his career with Procter and Gamble after graduating from Harvard College. He also earned an MBA from Boston University.

In addition to Cyberonics, he serves on the boards of Trivascular, Inc., Medical Device Manufacturers Association (MDMA), BioHouston, Weldon School of Biomedical Engineering at Purdue University, the Epilepsy Foundation of Texas and the National Epilepsy Foundation.

Board: Paul Klotman

Fri, 16 Sep 2011 15:00:40 GMT

Paul Klotman, M.D.
President & CEO
Baylor College of Medicine

Paul Klotman, M.D., assumed the post of President and CEO at Baylor College of Medicine Sept. 1, 2010. Dr. Klotman received his B.S. degree in 1972 from the University of Michigan and his M.D. from Indiana University in 1976. He completed his Medicine and Nephrology training at Duke University Medical Center. He stayed at Duke as a faculty member, rising to the rank of Associate Professor of Medicine before moving to the NIH in 1988 where he became Chief of the Molecular Medicine Section in the Laboratory of Developmental Biology. In 1993, he became Chief of the Viral Pathogenesis Laboratory in the NIDR/NIH. In 1994 he moved to Mt. Sinai School of Medicine as the Irene and Dr. Arthur M. Fishberg Professor of Medicine and the Chief, Division of Nephrology. In 2001, he was selected to be the Chairman of the Samuel Bronfman Department of Medicine. Dr. Klotman is a noted scientist whose work has included both basic and clinical research in molecular virology and AIDS pathogenesis. He has been an active clinician, teacher, and mentor.

BioHouston Breakfast Forum

Mon, 23 May 2011 21:53:44 GMT

Tuesday, June 21st, 2011 7:30 AM- 9:00 AM James T. Willerson, MD, President, Texas Heart Institute James T. Willerson, MD, is the president and medical director, director of Cardiology Research, and co-director of the Cullen Cardiovascular Research Laboratories at Texas Heart Institute (THI). In 1989, he was named the Edward Randall III Chair, Department of Internal Medicine at The University of Texas Medical School at Houston. He was president of The University of Texas Health Science Center at Houston from 2001 to 2008 and was named the Alkek-Williams Distinguished Professor there at the same time. Dr. Willerson was appointed president-elect of THI in 2004 and became president and medical director in 2008. He is also an adjunct professor of Medicine at Baylor College of Medicine and at The University of Texas MD Anderson Cancer Center. He is the former chief of Cardiology at St. Luke's Episcopal Hospital and the former chief of...

2010 Life Science CEO Summit Feedback

noemail@biohouston.org — Thu, 04 Mar 2010 23:00:00 GMT

Objectives: To help us make the CEO Summit more relevant to your business, we ask that you complete this short survey to let us know your thoughts.

Release Date: 4-Mar-10 5:00 PM
Expiration Date: 2-Jun-10 5:00 PM

Please fill in the survey. You responses will be forwarded to BioHouston for tabulation and review.

Texas Life Science Conference -- Emerging Company Survey

noemail@biohouston.org — Thu, 28 Aug 2008 20:00:00 GMT

Objectives: At the 2008 Texas Life Science Conference, your company has the opportunity to benefit from several add-on events not available to the regular attendee. Please take this quick and easy survey to better help us serve you.

Release Date: 28-Aug-08 3:00 PM
Expiration Date: 26-Nov-08 3:00 PM
Please fill out the following survey and someone from the BioHouston staff will be in touch with you shortly regarding registration materials and payment options.

Strategic Planning Initial Test

noemail@biohouston.org — Wed, 16 Jan 2008 16:00:00 GMT

Objectives: BioHouston will use this data to prepare for the future.

Release Date: 16-Jan-08 10:00 AM
Expiration Date: 15-Apr-08 10:00 AM

DSC01257

Fri, 24 May 2013 19:36:39 GMT

Our Best of Show Chili Winners, CitareTx Investment Partners!

DSC01249

Fri, 24 May 2013 19:36:39 GMT